ONESOURCE SPECL PHARMA L vs ZYDUS LIFESCIENCES LTD
A side-by-side comparison of ONESOURCE SPECL PHARMA L (ONESOURCE) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, ZYDUS LIFESCIENCES LTD leads ONESOURCE vs ZYDUSLIFE on 9 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- − ["Stock is trading at 3.20 times its book value", "Company has low interest coverage ratio.", "Company has a low return on equity of -2.39% over last 3 years.", "Promoters have pledged 38.4% of their holding.", "Company has high debtors of 177 days."]
- + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.